Product image of Konika (Fluticasone Furoate) supplied by GNH India

Konika

Active Ingredient:
Fluticasone Furoate
Origin:
EU

Konika (Fluticasone Furoate)

Fluticasone furoate, the active ingredient in Konika, is a corticosteroid presented as a nasal spray for nasal administration. It reduces inflammation of the nasal mucosa and is indicated for the relief of symptoms associated with allergic rhinitis and nasal congestion in both adult and pediatric patients.

GNH India supplies Konika as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured nasal corticosteroid therapy with flexible order volumes and compliance with global regulatory standards.

Manufacturer / TM Owner

Substipharm

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Fluticasone furoate nasal spray is used to manage inflammatory conditions of the nasal passages, primarily allergic rhinitis.

  • Allergic rhinitis: reduces sneezing, itching, and runny nose.
  • Nasal congestion: decreases swelling of nasal mucosa to improve airflow.
  • Seasonal allergic rhinitis: provides symptom relief during pollen exposure.

How It Works

  • Fluticasone furoate acts as an agonist at glucocorticoid receptors in the nasal mucosa, leading to transcriptional regulation that suppresses pro‑inflammatory cytokines, reduces vascular permeability, and inhibits leukocyte infiltration, thereby decreasing local inflammation and edema.

Side Effects

Fluticasone furoate nasal spray may cause a range of adverse reactions.

Common Side Effects

  • Nasal irritation: mild burning or stinging sensation.
  • Headache: transient mild to moderate pain.
  • Epistaxis: occasional nosebleeds.
  • Altered taste: temporary metallic or bitter taste.
  • Throat irritation: soreness or dryness.
  • Cough: occasional dry cough.

Serious or Rare Side Effects

  • Nasal fungal infection: opportunistic growth of fungi in the nasal cavity.
  • Adrenal suppression: reduced endogenous cortisol production with prolonged high‑dose use.
  • Vision changes: rare cases of cataract formation or increased intra‑ocular pressure.
  • Severe allergic reaction: anaphylaxis with symptoms such as swelling, rash, or difficulty breathing.

Precautions & Warnings

When using Konika, consider the following safety measures.

  • Hypersensitivity: do not use if you have known allergy to fluticasone furoate or any excipient.
  • Nasal infections: avoid use during active bacterial, viral, or fungal sinus infections.
  • Glaucoma or cataracts: use with caution and consult an eye specialist if you have these conditions.
  • Pregnancy and breastfeeding: discuss risks with a healthcare professional before use.
  • Dose limitation: follow prescriber instructions and do not exceed recommended frequency.
  • Store at room temperature: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Fluticasone furoate nasal spray can interact with other medicines.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure.
  • Systemic corticosteroids: concurrent use can raise risk of systemic corticosteroid effects.

Moderate Interactions (Monitor Closely)

  • Intranasal decongestants: may cause rebound congestion if overused.
  • Antihistamines: may increase sedation, though rare.
  • Immunosuppressants: monitor for potential additive immunosuppression.

Frequently Asked Questions

Konika is a nasal spray containing fluticasone furoate, a corticosteroid indicated for the relief of symptoms associated with allergic rhinitis and nasal congestion. It helps reduce inflammation in the nasal passages, easing sneezing, itching, runny nose, and blockage.

Fluticasone furoate binds to glucocorticoid receptors in the nasal mucosa, modulating gene expression to suppress inflammatory cytokines, reduce vascular permeability, and limit leukocyte infiltration. This anti‑inflammatory action decreases swelling and mucus production, improving nasal airflow.

The dosing regimen for Konika is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and the product label for the number of sprays per nostril and frequency.

Safety of fluticasone furoate nasal spray in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning pregnancy, or nursing should discuss potential risks and benefits with their healthcare provider before using Konika.

To order Konika, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Konika’s active ingredient, fluticasone furoate, has a high receptor affinity and a long duration of action, allowing once‑daily dosing for many patients. Compared with older agents such as budesonide or fluticasone propionate, fluticasone furoate may offer improved symptom control with similar safety when used as directed.

Konika should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not store in bathrooms or other humid environments.

Konika is administered as a nasal spray. The user gently blows the nose, tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if required.

Serious but rare risks include nasal fungal infection, adrenal suppression with prolonged high‑dose use, and severe allergic reactions such as anaphylaxis. Patients should report any unusual bleeding, persistent sore throat, visual changes, or signs of systemic corticosteroid effects to their healthcare provider promptly.

Konika should not be used by individuals with a known hypersensitivity to fluticasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated nasal infections or severe nasal septal perforation, unless directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fluticasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT